Health
Survey finds support for medical cannabis among UK health professionals
65% of respondents said they thought medical cannabis should be available on the NHS.
Search
24 results for “grow-pharma”
Industry
First UK-grown cannabis medicine expected by end of 2023
Midlands-based medical cannabis producer Dalgety has announced a new agreement with Grow Pharma.
Science
Cannabis enhances ‘runner’s high’ during exercise, finds study
New research further supports the role of cannabinoids in the ‘runner’s high’ experience.
Industry
How allowing GPs to prescribe cannabis could ease the burden on NHS
Experts say giving GPs the right to prescribe cannabis would help drive down NHS waiting lists.
Comment
The doctor’s perspective: treating depression, anxiety and insomnia with cannabis
A UK cannabis prescriber shares what he has learned on his journey so far.
Science
New drug shows promise in treating cannabis use disorder
The drug has shown promise as the first safe and effective medication for cannabis use disorder (CUD).
News
$11.6m NIDA study to explore effects of cannabis in HIV
The study will investigate the potential risks and benefits of cannabis on the brains of those living with HIV.
Science
Major trial to study medicinal cannabis and endometriosis in Australia
It is thought to be the world’s first trial of its kind into medicinal cannabis and endometriosis.
Women's health
Cannabis and endometriosis: what we know so far
How can cannabis help manage symptoms of endometriosis and potentially treat the condition?
Health
Are cannabis consumers really more at risk of a heart attack?
We break down the findings from a new study on cannabis use disorder and coronary artery disease (CAD).
News
Malta’s cannabis club model to launch end of February – what you need to know
The Maltese Authority for the Responsible Use of Cannabis (ARUC) has announced the criteria for opening a cannabis club.
Science
Legalising cannabis does not increase substance misuse, finds study
New research refutes the theory that cannabis is a ‘gateway drug’.
News
NHS reimburses cost of unlicensed cannabis treatment in ‘rare’ adult case
Patients and advocates in the UK have welcomed the news but warned of a need to ‘manage expectations’.
Science
Latest cannabis research: five new studies to know about
New studies explore cannabis for sleep, muscle recovery, CUD, MS and IBD.
Insight
Medicinal cannabis in Spain: inside the country’s first ‘cannabis clinic’
Draft regulations for the legalisation of medicinal cannabis in Spain are expected any day.
Wellness
Dry January: how cannabis can help cure the holiday hangover
Could cannabis be your secret weapon for staying alcohol-free in 2023?
Industry
What are intoxicating hemp-derived cannabinoids (IHDCs), and are they safe?
A new hemp-based high is on the rise in Europe, but is it safe?
Endometriosis
Irish endometriosis patient celebrates cannabis prescription success
Aimee Brown is thought to be the first endometriosis patient to be prescribed cannabis under the ministerial licence scheme.
News
Sapphire Access Scheme expands to offer more patients reduced costs
The scheme, which reduces the cost of cannabis treatment, is now open to an additional 2,000 patients
News
Study to explore cannabis in children receiving non-cancer palliative care
The project will be the first in the world to investigate the feasibility of a medicinal cannabis clinical trial in this patient group.
Industry
Crowdfunder launched for key study into cost-benefits of cannabis on NHS
A full health economic analysis hopes to show cannabis could be prescribed on the NHS at ‘net-zero’ cost.
Industry
Grow Pharma apologises for price rises, blaming ‘escalating costs’
The company’s flower-based cannabis products have increased in price by 50p per gram.
Industry
Cannabis Clinic Cardiff joins Grow Access Project reducing barriers to prescriptions
The move aims to further reduce cost-related barriers to medical cannabis prescriptions.
CBD
Over-the-counter CBD vs prescription cannabis – understanding the difference
The Medical Cannabis Clinicians Society has published guidance for CBD consumers.